SERO-SALIVARY PROGESTERONE CORRELATION

被引:12
作者
BOLAJI, II [1 ]
机构
[1] UNIV COLL HOSP GALWAY,ACAD DEPT OBSTET & GYNAECOL,CLIN RES UNIT,GALWAY,IRELAND
关键词
SALIVARY STEROIDS; PROGESTERONE; ENZYMOIMMUNOASSAY;
D O I
10.1016/0020-7292(94)90119-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVES: The use of saliva has many advantages and the concentration of some sex steroids in saliva generally reflect serum levels. However, recently doubts have been cast on this relationship [1,2]. This study was undertaken to establish any correlation between serum and salivary progesterone in quiescent and dynamic states. METHODS. Serum and salivary progesterone were measured in normally cycling (N = 23), pregnant (N = 10) and 5 postmenopausal women on hormone replacement therapy, using non-isotopic enzyme immunoassay on microtiter plates developed in this unit. RESULTS: Salivary progesterone was found to be approximately 1% of serum progesterone in normally cycling and pregnant women. There was good positive correlation between serum and salivary progesterone in normally cycling, pregnant and the postmenopausal women. The linear regression equation is y = 0.009x + 0.035: r = 0.987, P < 0.001; y = -0.011x -0.079:r = 0.958, P < 0.001; and y = 0.014x+ 1.18: r = 0.714, P < 0.001, respectively. The maximum concentration of progesterone in postmenopausal women was achieved simultaneously in serum and saliva at 2 h post therapy thereby supporting the theory of rapid ultrafiltration of steroids from blood to saliva [3]. CONCLUSIONS: Salivary progesterone measurement reflects serum concentration and provide an attractive alternative to serum measurement. It should become increasingly popular in gynecological and endocrinological investigations especially in longitudinal studies.
引用
收藏
页码:125 / 131
页数:7
相关论文
共 16 条
[1]  
Bolaji I. I., 1992, Journal of Obstetrics and Gynaecology (Abingdon), V12, P412, DOI 10.3109/01443619209025947
[2]   THE RETURN OF POSTPARTUM FERTILITY MONITORED BY ENZYME-IMMUNOASSAY FOR SALIVARY PROGESTERONE [J].
BOLAJI, II ;
TALLON, DF ;
MEEHAN, FP ;
ODWYER, EM ;
FOTTRELL, PF .
GYNECOLOGICAL ENDOCRINOLOGY, 1992, 6 (01) :37-48
[3]   LOW-DOSE PROGESTERONE THERAPY IN ESTROGENIZED POSTMENOPAUSAL WOMEN - EFFECTS ON PLASMA-LIPIDS, LIPOPROTEINS AND LIVER-FUNCTION PARAMETERS [J].
BOLAJI, II ;
GRIMES, H ;
MORTIMER, G ;
TALLON, DF ;
FOTTRELL, PF ;
ODWYER, EM .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1993, 48 (01) :61-68
[4]  
BOLAJI II, 1992, J IRISH COLL PHYS SU, V21, P117
[5]  
EVANS JJ, 1986, CLIN CHEM, V32, P542
[6]  
LEQUIN RM, 1986, CLIN CHEM, V32, P831
[7]  
LUISI M, 1984, FRONTIERS ORAL PHYSL, V5, P124
[8]  
MANDEL ID, 1990, J ORAL PATHOL MED, V19, P11
[9]  
MAXSON WS, 1985, FERTIL STERIL, V44, P622
[10]   PLASMA LEVELS OF PROGESTERONE AFTER VAGINAL, RECTAL, OR INTRAMUSCULAR ADMINISTRATION OF PROGESTERONE [J].
NILLIUS, SJ ;
JOHANSSON, ED .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1971, 110 (04) :470-+